INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 127 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $49,000 | -56.2% | 15,000 | -50.0% | 0.01% | -61.5% |
| Q1 2019 | $112,000 | +0.9% | 30,000 | +50.0% | 0.01% | +550.0% |
| Q3 2018 | $111,000 | -23.4% | 20,000 | -45.9% | 0.00% | -33.3% |
| Q2 2018 | $145,000 | +49.5% | 37,000 | +80.5% | 0.00% | +50.0% |
| Q1 2018 | $97,000 | -71.2% | 20,500 | -61.4% | 0.00% | -66.7% |
| Q3 2017 | $337,000 | +83.2% | 53,100 | +126.0% | 0.01% | +100.0% |
| Q2 2017 | $184,000 | +85.9% | 23,500 | +56.7% | 0.00% | +50.0% |
| Q1 2017 | $99,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Triatomic Management LP | 235,000 | $405,000 | 0.23% |
| Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
| Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
| Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
| Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
| Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
| CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
| Keystone Financial Group | 74,058 | $128,000 | 0.03% |
| Virtu Financial LLC | 130,829 | $226,000 | 0.02% |